| Name | Title | Contact Details |
|---|
At Magellan Health, we have a unique vision of better and more affordable care in the fast growing, highly complex and high cost areas of health care. Our complete-person perspective helps us deliver better outcomes and brighter futures. Magellan Health, Inc. is a health care management company headquartered in Scottsdale, AZ. The depth and breadth of our experience in managing behavioral health care, diagnostic imaging, specialty pharmaceutical services and in providing pharmacy benefits administration enable us to deliver inspired insights and innovative solutions that positively impact both the quality and the cost of some of the nation`s fastest growing areas of health care. Magellan is proud to be a founding member of Hero Health Hire, a coalition of health care companies committed to recruiting, hiring and training veterans, wounded warriors and military spouses.
Get hassle-free reproductive care for Herpes, BV, Yeast, UTI, Primary Care & Contraception. Same-day prescriptions picked up locally in a few hours or delivered FREE, discreetly packaged, to your home.
Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.
JSS Medical Research is a Westmount, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bass Lake Pet Hospital is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.